The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, ...

A 61-year-old man allegedly stabbed by his 26-year-old son in Pearl City Sunday night told police his son suffers from schizophrenia and was off his medication at the time of the attack, according to ...